GHRL and Parkinson disease: Ghrelin targets the AMP-activated protein kinase (AMPK) in dopamine neurons, as recently reported in an in vitro study (Bayliss et al., 2016) as well as in different animal models of PD (Horvath et al., 2011; Ng et al., 2012).